Drug Trial Radar · NCT04576949
A Study of Cytisinicline for Smoking Cessation in Adult Smokers
Last checked: Nov 20, 2026Latest source record: Jan 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
810
Actual
Start
Oct 13, 2020
Primary completion
Dec 23, 2021
Study completion Dec 23, 2021
Sponsor
- Lead sponsor
- Achieve Life SciencesIndustry
- Sponsor type
- Industry
- First posted
- Oct 6, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This placebo-controlled Phase 3 study is being conducted at sites within the United States to evaluate 3 mg cytisinicline 3 times daily (TID) for treatment duration of 42 days/6 weeks and evaluate 3 mg cytisinicline TID for treatment duration of 84 days/12 weeks.
Conditions
- Smoking Cessation
Interventions
CytisiniclineDrug
film-coated oral tablets containing 3 mg cytisinicline
PlaceboDrug
film-coated oral tablets containing matched placebo
Behavioral supportBehavioral
Behavioral support sessions by a qualified study site staff member will be participant-driven and will include direct engagement with the subject about their attempt to quit smoking. Each session will last approximately 10 minutes.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Smoking Abstinence From Weeks 3 to Week 6Time frame: Weeks 3 to 6
- Percentage of Participants With Smoking Abstinence From Weeks 9 to Week 12Time frame: Weeks 9 to 12
Locations
17 sites in 1 country. Site status is shown where the registry gives one.
Alliance for Multispecialty Research, LLC.
Mobile, Alabama
Arizona State University
Phoenix, Arizona
Alliance for Multispecialty Research, LLC
Coral Gables, Florida
Clinical Research Atlanta
Atlanta, Georgia
MediSphere Medical Research Center, LLC
Evansville, Indiana
Alliance for Multispecialty Research, LLC
Wichita, Kansas
AMR Lexington
Lexington, Kentucky
Alliance for Multispecialty Research, LLC
New Orleans, Louisiana
Massachusetts General Hospital - Clinical Genetic Research Facility
Boston, Massachusetts
Alliance for Multispecialty Research, LLC
Kansas City, Missouri
Alliance for Multispecialty Research, LLC
Las Vegas, Nevada
Rochester Clinical Research, Inc.
Rochester, New York
M3 Wake Research, Inc.
Raleigh, North Carolina
Coastal Carolina Research Center, Inc.
Mt. Pleasant, South Carolina
Alliance for Multispecialty Research, LLC.
Knoxville, Tennessee
FutureSearch Trials of Dallas, LP
Dallas, Texas
Alliance for Multispecialty Research, LLC
Norfolk, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.